Identification of HIV-1 specific T lymphocyte responses in highly exposed persistently seronegative Chinese

Chinese Medical Journal

Volumn 119, Issue 19, 2006, Pages 1616-1621

  Liu, Hong Wei ^a   Hong, Kun Xue ^a   Ma, Jun ^b   Yuan, Lin ^a   Liu, Sha ^a   Chen, Jian Ping ^a   Zhang, Yuan Zhi ^b   Ruan, Yu Hua ^a   Xu, Jian Qing ^a   Shao, Yi Ming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Xinjiang Center for Disease Prevention and Control   (China)

Author keywords

Cytotoxic; Highly exposed persistently seronegative; HIV seropositivity; T lymphocytes

Indexed keywords

GAG PROTEIN; GAMMA INTERFERON; POL PROTEIN; PROTEIN SUBUNIT; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VPR PROTEIN; VPU PROTEIN;

ADULT; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; EXPOSURE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PROTEIN TARGETING; SERODIAGNOSIS; SEXUAL INTERCOURSE; T LYMPHOCYTE;

EID: 33750067347     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200610010-00005     Document Type: Article

References (20)

1. Frahm N, Kiepiela P, Adams S, Linde CH, Hewitt HS, Sango K, et al. Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol 2006; 7: 173-178.
2. Shang H, Han XX, Wang YN, Zhou LP, Zhang ZN, Jiang YJ, et al. Specific cytotoxic T lymphocyte responses in Chinese HIV/AIDS patients. Chin Med J 2004; 117: 1570-1572.
3. + T-cell responses: relationship to viral load in untreated HIV infection. J Virol 2001; 75: 11983-11991.
4. Brander C, Walker BD. T lymphocyte responses in HIV-1 infection: implications for vaccine development. Curr Opin Immunol 1999; 11: 451-459.
5. Frahm N, Korber BT, Adams JJ, Szinger R, Draenert MM, Addo ME, et al. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across across multiple ethnicities. J Virol 2004; 78: 2187-2200.
6. + lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Invest 2001; 107: 1303-1310.
7. Bernard N, Yannakis C, Lee J, Tsoukas CM. Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed sero-negative persons. J Infect Dis 1999; 179: 538-547.
8. Bienzele D, MacDonald K, Smaill F, Kovacs C, Baqi M, Courssaris B, et al. Factors contributing to the lack of human immunodeficiency virus type 1 (HIV-1) transmission in HIV-1-discordant partners. J Infect Dis 2000; 182: 123-132.
9. Sriwanthana B, Hodge T, Mastro TD, Dezzutti CS, Bond K, Stephens HA, et al. HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand. AIDS Res Hum Retroviruses 2001; 17: 719-734.
10. McNicholl JM, Promadej N. Insights into the role of host genetic and T-cell factors in resistance to HIV transmission from studies of highly HIV-exposed Thais. Immunol Res 2004; 29: 161-174.
11. Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996; 348: 1347-1351.
12. Rowland-Jones SL, Pinheiro S, Kaul R, Hansasuta P, Gillespie G, Dong T, et al. How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection? Immunol Lett 2001; 79: 15-20.
13. Shearer GM, Clerici M. Protective immunity against HIV infection: Has nature done the experiment for us? Immunol Today 1996; 17: 21-24.
14. Clerici M, Clark EA, Polacino P, Axberg I, Kuller L, Casey NI, et al. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 1994; 8: 1391-1395.
15. + T cell responses following acute HIV-1 infection. J Virol 2002; 76: 8690-8701.
16. Wang FS, Hong WG, Cao Y, Liu MX, Jin L, Hu LP, et al. Population survey of CCR5 delta32, CCR5 m303, CCR2b 641, and SDF1 3′A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups. J Acquir Immune Defic Syndr 2003; 32: 124-130.
17. Zhang C, Fu S, Xue Y, Wang Q, Huang X, Wang B, et al. Distribution of the CCR5 gene 32-basepair deletion in 11 Chinese populations. Anthropol Anz 2002; 60: 267-271.
18. Goulder PJ, Altfeld MA, Rosenberg E, Nguyen T, Tang Y, Eldridge RL, et al. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic infection. J Exp Med 2001; 193: 181-193.
19. Clerici M, Clark EA, Polacino P, Axberg I, Kuller L, Casey NI, et al. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 1994; 8: 1391-1395.
20. Mazzoli S, Trabattoni D, Caputo SL, Piconi S, Ble C, Meacci F, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997; 3: 1250-1257.